SparingVision

SparingVision Overview

Founded 2016
Founded
Status Private
Latest Deal Type Accelerator/​Inc
Latest Deal Amount $2.82M
Latest Deal Amount
Investors 5

SparingVision General Information

Description

Developer of a medical therapy intended to treat inherited blinding retinal disease retinitis pigmentosa. The company's offerings include a drug candidate to treat retinitis pigmentosa, the most frequent inherited retinal degeneration which can progress to blindness and affects 2 million patients worldwide, enabling doctors to help patients recover from retinal diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 55 rue de lyon
  • 75012 Paris
  • France

SparingVision Timeline

2017201820192020
Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SparingVision Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 09-Jul-2019 $2.82M 0000 Completed Startup
3. Early Stage VC 10-Dec-2017 00.000 00.00 00.00 Completed Startup
2. Early Stage VC 15-Dec-2016 $2.12M $2.12M 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup

SparingVision Cap Table

To view SparingVision‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Shares 00,000 00.000000 0000.00 0000.00 00 0000.00 000

SparingVision Executive Team (4)

Name Title Board Seat Contact Info
Florence Ghrenassia Ph.D President & Chief Executive Officer
Thierry Léveillard Ph.D Co-Founder
José-Alain Sahel Ph.D Co-Founder
Stephane Boissel Chairman

SparingVision Board Members (1)

Name Representing Role Since
Stephane Boissel Self Chairman 000 0000

SparingVision Investors (5)

To view SparingVision‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
EIT Health Accelerator/Incubator Minority 000 0000 000000 0
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
Fondation Voir et Entendre Other Minority 000 0000 000000 0
Foundation Fighting Blindness-National Neurovision Research Institute Not-For-Profit Venture Capital Minority 000 0000 000000 0
Incubateur Insitut de La Vision Accelerator/Incubator 000 0000 000000 0

Ready to get started?

Request a free trial